VAN ZUILEN WILFRED 4

What Happened
Wilfred Van Zuilen, Group President, EMEA for Zimmer Biomet (ZBH), had 3,182 restricted stock units (RSUs) vest on February 25, 2026. The RSUs converted to common shares (reported as exercise/conversion of a derivative). The company withheld 828 shares to cover tax obligations at $99.51 per share, equal to about $82,394. Net shares delivered to him were 2,354. The vested RSUs were worth roughly $316,641 at the $99.51 share price.

Key Details

• Transaction date: 2026-02-25; filing date: 2026-02-27 (filed timely).
• Reported actions/codes: M = exercise/conversion of derivative (RSU vesting); F = shares withheld for tax withholding.
• Shares: 3,182 RSUs vested and converted; 828 shares withheld (disposed) at $99.51 ($82,394); net 2,354 shares retained.
• Approximate values: total vested value ≈ $316,641; withheld value ≈ $82,394; net value retained ≈ $234,247.
• Shares owned after the transaction: not disclosed in the filing.
• Footnotes: F1 — shares were withheld by the company to satisfy tax withholding on RSU vesting; F2 — this was one‑third of an RSU grant (remaining vesting: 50% on 2/25/2027 and 50% on 2/25/2028).

Context
This was not an open‑market purchase or a discretionary sale by the insider but a routine vesting of RSUs with net share settlement (company withheld shares to pay taxes). Such transactions reflect compensation vesting rather than a directional trade signal.